home / stock / eryp / eryp news


ERYP News and Press, Erytech Pharma S.A. From 09/22/20

Stock Information

Company Name: Erytech Pharma S.A.
Stock Symbol: ERYP
Market: NASDAQ

Menu

ERYP ERYP Quote ERYP Short ERYP News ERYP Articles ERYP Message Board
Get ERYP Alerts

News, Short Squeeze, Breakout and More Instantly...

ERYP - ERYTECH Pharma S.A. 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by ERYTECH Pharma S.A. in conjunction with their 2020 Q2 earnings call. For further details see: ERYTECH Pharma S.A. 2020 Q2 - Results - Earnings Call Presentation

ERYP - ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q2 2020 Results - Earnings Call Transcript

ERYTECH Pharma S.A. (ERYP) Q2 2020 Earnings Conference Call September 22, 2020 8:30 A.M. ET Company Participants Gil Beyen - Chief Executive Officer Eric Soyer - Chief Financial Officer and Chief Operating Officer Iman El-Hariry - Chief Medical Officer Conference Call Participants Fred Gomez ...

ERYP - Erytech inks $30M stock sales deal with Cowen

ERYTECH Pharma (ERYP) inks at-the-market sales agreement with Cowen for the sale of ordinary shares in the form of American Depositary Shares (ADSs) for gross sales proceeds of up to $30M.The ATM program will be effective until September 21, 2023, unless terminated prior to such date. Net pro...

ERYP - ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen

LYON, France, Sept. 21, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris : ERYP - Nasdaq : ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances in red blood cells (the "Company"), today announced the implementation of an...

ERYP - ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update

LYON, France, Sept. 16, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its sec...

ERYP - ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment

More than 450 of the planned ~ 500 patients enrolled Interim superiority analysis expected around year-end 2020 Call with KOL Dr. Manuel Hidalgo on September 29, 2020 at 10:00 am ET LYON, France and CAMBRIDGE, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq &a...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - August 31, 2020

LYON, France, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) &am...

ERYP - Erytech Pharma: Exploring New Ways To Battle Cancer

Introduction This century has brought us tremendous progress, many of which are in the field of information technology. The highly restrictive field of healthcare seems to move relentlessly forward with innovative projects, such as Neuralink or digitalized medicine. However, in the case of...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - July 31, 2020

LYON, France, Aug. 06, 2020 (GLOBE NEWSWIRE) --   Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) ...

ERYP - Monthly information related to total number of voting rights and shares composing the share capital - June 30, 2020

LYON, France, July 10, 2020 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -  ISIN Code: FR0011471135- Symbol: ERYP) & ...

Previous 10 Next 10